Open AccessRandomized clinical trial to assess the impact of the broadly neutralizing HIV-1 monoclonal antibody VRC01 on HIV-1 persistence in individuals on effective ART
Author(s) -
S.A. Riddler,
L. Zheng,
C.M. Durand,
J. Ritz,
R.A. Koup,
J. Ledgerwood,
R.T. Bailer,
S.L. Koletar,
Joe Eron,
M.C. Keefer,
B.J.C. Macatangay,
J.C. Cyktor,
J.W. Mellors,
Molly Hite,
J. Clark,
D. Currin,
M. Tipton,
R. Weinman,
S. Onesi,
C. Hurley,
C.A. Bunce,
S. Storey,
S. Dunaway,
N. Lambert,
B. Berzins,
J. Gottesman,
M. Leonard,
G. Ray,
P. Kittelson,
C. Benson,
L. Muttera,
T. Flynn,
A. Sbrolla,
I. Wiggins,
J. Howard,
R.C. Arduino,
A.E. Villamil,
L. Kessels,
T. Spitz,
D. Campbell,
M. Kudumu,
T. Sise,
A. Nair,
J. Baer,
K. Epperson,
A. Perelson,
C. Jennings,
R. Tressler,
Ed. Acosta,
J. Casazza,
A. Benns,
AIDS Clinical Trials Group A Protocol Team
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/p8th-zw41
Subject(s) - persistence (discontinuity) , monoclonal antibody , human immunodeficiency virus (hiv) , virology , medicine , randomized controlled trial , clinical trial , antibody , immunology , geotechnical engineering , engineering